Jury Says Apple Owes Masimo $634M: What Happened?
A California federal jury has ruled that Apple must pay Masimo $634 million for infringing a patent related to blood oxygen monitoring technology. The lawsuit focused on Apple Watch features like workout mode and heart rate notifications. This verdict highlights the ongoing battle over medical tech patents and raises questions about Apple’s future innovation strategy.
Image Credits:Brian Heater
How Did Apple Infringe Masimo’s Patent?
The jury found that specific Apple Watch functionalities violated Masimo’s intellectual property. Masimo, a medical device company, emphasized that protecting patents is crucial to developing life-enhancing technologies. Apple, on the other hand, claims the verdict is “contrary to the facts” and plans to appeal, noting that the disputed patent expired in 2022.
What Does This Mean for Apple and Masimo?
For Masimo, the $634M award is a major win in defending their technology. It reinforces the importance of patent rights for smaller innovators. For Apple, the decision could impact product development and raise concerns about ongoing patent litigation. Legal experts suggest this may not be the end of a lengthy appeals process.
إرسال تعليق